» Download Public Reports
32 reports
- Company report
- January 2013
- 9 pages
... Identified infants with permanent hearing loss at 12 to 16 months of age. pediatrics 122:535 544. 37. Puig t, municio a, meda C (2005) universal neonatal hearing screening versus selective screening as part ...
December 2012
... Burns, plastic surgery and dermatology conferences. Avita will continue to participate in these conferences, display its products and sponsor presentations on clinical results achieved with recell by high ...
September 2012
... Cardiology product, as well as several of its oncology products exclusively promoted in china for pfizer and baxter were reduced at or below the average price reduction announced by the government ...
June 2012
... Oxygenators, also named as artificial lung, are for the use in extra-corporal on-pump cardiac surgery, with the function of oxygenating the non-oxygenated blood into oxygenated blood. According ...
June 2012
... eye care * as of june 27, 2012, we have changed our organizational structure to three in-house companies. As a result, the former eye care business unit became the eye care company. The vision ...
May 2012
... Business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. Sciclone's zadaxin (thymalfasin ...
March 2012
... cardiology products (ivp) and critical care products (ccp). The ivp business is driven by the sales of its des products using technology developed in house. The company also collects royalty and licensing ...
December 2011
... Will be payable if the insured, after a hospital confinement whereby a daily hospital income benefit is payable, dies as a result (directly and independently of all other causes) of the negligence of a medical ...
December 2011
... Is a revenue-generating, profitable, specialty pharmaceutical company with a substantial commercial business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular ...
» Purchase Premium Reports
(From $ 250 - $ 844)
43 reports
- $ 898
- Industry report
- May 2013
- by Euromonitor International
In 2012, higher air pollution and uncomfortable eyes, driven by wearing contact lenses and using computers for a long daily time without sufficient eye rest, led to a positive value growth in sales. Hence, ...
April 2013
$ 898
Eye care continued its robust growth in both value and volume terms in China in 2012, thanks to growing consumer awareness and the effects of faster pace of life. According to China Internet Network Information ...
May 2013
$ 250
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
May 2013
$ 250
Summary HUYA Bioscience International, LLC (HUYA) is a privately held biopharmaceutical company, based in the US. It develops pre clinical and clinical drug candidates. The company focuses on the areas ...